Biotech Ingredients Market by Type (Active Pharmaceutical Ingredients and Biosimilars), Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, and Blood Factors), and Expression Systems (Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, and Insect Expression Systems): Global Opportunity Analysis and Industry Forecast, 2021–2028
- ALL4621687
- 300 Pages
- May 2021
- Materials and Chemicals
Biotech ingredients are compounds that consist of components with natural extracts, essential oils, and bio-engineered substances. These compounds are found in animals, plants, micro-organisms, and any natural living organisms. These complex structures are produced through processes such as hybridoma and genetic engineering.
Biotech ingredients are experiencing high demand over synthetic ingredients marking a huge shift in consumer base. This is attributed to rise in awareness among consumers regarding health benefits from organic and herbal medicines. Moreover, use of generic medicines has also increased significantly as current lifestyles, stress, and working habits have led to various health concerns, which acts as a driving factor for generic medicines. Increase in demand for generic medicines have also led to increase in shift toward use of biotech ingredients. In addition, rise in consumption in the food & beverages industry and various health supplements also drive growth of the biotech ingredients market growth. However, unavailability of raw materials acts as restraint for the biotech ingredients market growth.
The biotech ingredient market is segmented on the basis of type, product, application, and region. Depending on type, the market is segmented into active pharmaceutical ingredients (API) and biosimilars. By product, it is categorized into monoclonal antibodies, vaccines, hormones & growth factors, cytokines, fusion proteins, therapeutic enzymes, and blood factors. By expression systems, it is divided into mammalian expression systems, microbial expression systems, yeast expression systems, plant expression systems, and insect expression systems. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA (Latin America, Middle East, and Africa).
The key players operating in the market are Pfizer Inc., Novartis International AG, Merck & Co., Teva Pharmaceutical Industries Ltd., Mylan, Inc., Boehringer Ingelheim, Sanofi, AbbVie, Eli Lilly and Company, and AstraZeneca plc. The players in the market have adopted several strategies, such as type launch and business expansion, to sustain the market competition.
KEY BENEFITS FOR STAKEHOLDERS
• The report provides extensive qualitative and quantitative analysis of the current trends and future estimations of the biotech ingredients market from 2020 to 2027 to determine the prevailing opportunities.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• The biotech ingredients market forecast and estimations are based on factors impacting the market growth, in terms of value.
• Profiles of leading players operating in the market are provided to understand the global competitive scenario.
• The report provides extensive qualitative insights on the significant segments and regions exhibiting favorable biotech ingredients market share.
• The biotech ingredients market size is provided in terms of revenue.
• The report provides an in-depth analysis of the forecast along with the current and future biotech ingredients market trends.
KEY MARKET SEGMENTS
By Type
Active Pharmaceutical Ingredients
Biosimilars
By Product
Monoclonal Antibodies
Vaccines
Hormones and Growth Factors
Cytokines
Fusion Proteins
Therapeutic Enzymes
Blood Factors
By Expression Systems
Mammalian Expression Systems
Microbial Expression Systems
Yeast Expression Systems
Plant Expression Systems
Insect Expression Systems
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia-Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia-Pacific
LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA
Key Players
o Pfizer Inc.
o Novartis International AG
o Merck & Co.
o Teva Pharmaceutical Industries Ltd.
o Mylan, Inc.
o Boehringer Ingelheim
o Sanofi
o AbbVie
o Eli Lilly and Company
o AstraZeneca plc
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Value chain analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Shift in consumer preference from synthetic to bio-based ingredients
3.5.1.2.Development in biotechnology
3.5.2.Restraint
3.5.2.1.Limited availability of raw material
3.5.3.Opportunity
3.5.3.1.Favorable government policies and technological advancements in bio-engineering
3.6.Patent analysis
3.7.Impact of COVID-19 on the biotech ingredients market
CHAPTER 4:BIOTECH INGREDIENTS MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Active pharmaceutical ingredients
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.3.Biosimilars
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
CHAPTER 5:BIOTECH INGREDIENTS MARKET, BY PRODUCT
5.1.Overview
5.1.1.Market size and forecast
5.2.Monoclonal antibodies
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.3.Vaccines
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.4.Hormones & growth factors
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.5.Cytokines
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.6.Fusion proteins
5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region
5.7.Therapeutic enzymes
5.7.1.Key market trends, growth factors, and opportunities
5.7.2.Market size and forecast, by region
5.8.Blood factors
5.8.1.Key market trends, growth factors, and opportunities
5.8.2.Market size and forecast, by region
CHAPTER 6:BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS
6.1.Overview
6.1.1.Market size and forecast
6.2.Mammalian expression systems
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.3.Microbial expression systems
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.4.Yeast Expression Systems
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.5.Plant Expression Systems
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by region
6.6.Insect expression systems
6.6.1.Key market trends, growth factors, and opportunities
6.6.2.Market size and forecast, by region
CHAPTER 7:BIOTECH INGREDIENTS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by type
7.2.3.Market size and forecast, by product
7.2.4.Market size and forecast, by expression systems
7.2.5.Market size and forecast, by country
7.2.6.U.S.
7.2.6.1.Market size and forecast, by type
7.2.6.2.Market size and forecast, by product
7.2.6.3.Market size and forecast, by expression systems
7.2.7.Canada
7.2.7.1.Market size and forecast, by type
7.2.7.2.Market size and forecast, by product
7.2.7.3.Market size and forecast, by expression systems
7.2.8.Mexico
7.2.8.1.Market size and forecast, by type
7.2.8.2.Market size and forecast, by product
7.2.8.3.Market size and forecast, by expression systems
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by type
7.3.3.Market size and forecast, by product
7.3.4.Market size and forecast, by expression systems
7.3.5.Market share analysis, by country
7.3.6.Germany
7.3.6.1.Market size and forecast, by type
7.3.6.2.Market size and forecast, by product
7.3.6.3.Market size and forecast, by expression systems
7.3.7.UK
7.3.7.1.Market size and forecast, by type
7.3.7.2.Market size and forecast, by product
7.3.7.3.Market size and forecast, by expression systems
7.3.8.France
7.3.8.1.Market size and forecast, by type
7.3.8.2.Market size and forecast, by product
7.3.8.3.Market size and forecast, by expression systems
7.3.9.Italy
7.3.9.1.Market size and forecast, by type
7.3.9.2.Market size and forecast, by product
7.3.9.3.Market size and forecast, by expression systems
7.3.10.Spain
7.3.10.1.Market size and forecast, by type
7.3.10.2. Market size and forecast, by product
7.3.10.3. Market size and forecast, by expression systems
7.3.11.Rest of Europe
7.3.11.1. Market size and forecast, by type
7.3.11.2. Market size and forecast, by product
7.3.11.3.Market size and forecast, by expression systems
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by type
7.4.3.Market size and forecast, by product
7.4.4.Market size and forecast, by expression systems
7.4.5.Market share analysis, by country
7.4.6.China
7.4.6.1.Market size and forecast, by type
7.4.6.2.Market size and forecast, by product
7.4.6.3.Market size and forecast, by expression systems
7.4.7.Japan
7.4.7.1.Market size and forecast, by type
7.4.7.2.Market size and forecast, by product
7.4.7.3.Market size and forecast, by expression systems
7.4.8.India
7.4.8.1.Market size and forecast, by type
7.4.8.2.Market size and forecast, by product
7.4.8.3.Market size and forecast, by expression systems
7.4.9.South Korea
7.4.9.1.Market size and forecast, by type
7.4.9.2.Market size and forecast, by product
7.4.9.3.Market size and forecast, by expression systems
7.4.10.Australia
7.4.10.1.Market size and forecast, by type
7.4.10.2.Market size and forecast, by product
7.4.10.3.Market size and forecast, by expression systems
7.4.11.Rest of Asia-Pacific
7.4.11.1.Market size and forecast, by type
7.4.11.2.Market size and forecast, by product
7.4.11.3.Market size and forecast, by expression systems
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by type
7.5.3.Market size and forecast, by product
7.5.4.Market size and forecast, by expression systems
7.5.5.Market share analysis, by country
7.5.6.Brazil
7.5.6.1.Market size and forecast, by type
7.5.6.2.Market size and forecast, by product
7.5.6.3.Market size and forecast, by expression systems
7.5.7.Saudi Arabia
7.5.7.1.Market size and forecast, by type
7.5.7.2.Market size and forecast, by product
7.5.7.3.Market size and forecast, by expression systems
7.5.8.South Africa
7.5.8.1.Market size and forecast, by type
7.5.8.2.Market size and forecast, by product
7.5.8.3.Market size and forecast, by expression systems
7.5.9.Rest of LAMEA
7.5.9.1.Market size and forecast, by type
7.5.9.2.Market size and forecast, by product
7.5.9.3.Market size and forecast, by expression systems
CHAPTER 8:COMPETITIVE LANDSCAPE
8.1.Introduction
8.1.1.Market player positioning, 2020
8.2.Top winning strategies
8.2.1.Top winning strategies, by year
8.2.2.Top winning strategies, by development
8.2.3.Top winning strategies, by company
8.3.Key developments
8.3.1.Acquisitions
8.3.2.New Product launches
CHAPTER 9:COMPANY PROFILES
9.1.AstraZeneca plc
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating Segments
9.1.4.Product portfolio
9.1.5.Business performance
9.2.Merck & Co.
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating Segments
9.2.4.Product portfolio
9.2.5.Business performance
9.3.Abbvie
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Product portfolio
9.3.4.Business performance
9.3.5.Key Developmental strategies
9.4.MYLAN N.V.
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Type portfolio
9.4.4.Business performance
9.4.5.Key Developmental strategies
9.5.NOVARTIS INTERNATIONAL AG
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Type portfolio
9.5.5.Business performance
9.6.PFIZER INC.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Type portfolio
9.6.5.Business performance
9.7.SANOFI S.A.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Type portfolio
9.7.5.Business performance
9.8.Boehringer Ingelheim
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Product portfolio
9.9.TEVA PHARMACEUTICAL INDUSTRIES LTD.
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Type portfolio
9.9.4.Business performance
9.10.ELI LILLY AND COMPANY
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Product portfolio
9.10.4.Business performance
TABLE 01.GLOBAL BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 02.ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 03.BIOSIMILARS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 04.GLOBAL BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 05.MONOCLONAL ANTIBODIES BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 06.VACCINES BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 07.HORMONES & GROWTH FACTORS BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 08.CYTOKINES BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 09.FUSION PROTEINS BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 10.THERAPEUTIC ENZYMES BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 11.BLOOD FACTORS BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 12.GLOBAL BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 13.BIOTECH INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2020–2028 ($MILLION)
TABLE 14.BIOTECH INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY REGION, 2020–2028 ($MILLION)
TABLE 15.BIOTECH INGREDIENTS MARKET, FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2028 ($MILLION)
TABLE 16.BIOTECH INGREDIENTS MARKET FOR PLANT EXPRESSION SYSTEMS, BY REGION, 2020–2028 ($MILLION)
TABLE 17.BIOTECH INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY REGION, 2020–2028 ($MILLION)
TABLE 18.BIOTECH INGREDIENTS MARKET, BY REGION, 2020--2028 ($MILLION)
TABLE 19.NORTH AMERICA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 20.NORTH AMERICA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 21.NORTH AMERICA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 22.NORTH AMERICA BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 23.U.S. BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 24.U.S. BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 25.U.S. BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 26.CANADA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 27.CANADA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 28.CANADA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 29.MEXICO BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 30.MEXICO BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 31.MEXICO BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 32.EUROPE BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 33.EUROPE BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 34.EUROPE BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 35.EUROPE BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 36.GERMANY BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 37.GERMANY BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 38.GERMANY BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 39.UK BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 40.UK BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 41.UK BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 42.FRANCE BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 43.FRANCE BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 44.FRANCE BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 45.ITALY BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 46.ITALY BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 47.ITALY BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 48.SPAIN BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 49.SPAIN BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 50.SPAIN BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 51.REST OF EUROPE BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 52.REST OF EUROPE BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 53.REST OF EUROPE BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 54.ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 55.ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 56.ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 57.ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 58.CHINA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 59.CHINA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 60.CHINA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 61.JAPAN BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 62.JAPAN BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 63.JAPAN BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 64.INDIA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 65.INDIA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 66.INDIA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 67.SOUTH KOREA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 68.SOUTH KOREA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 69.SOUTH KOREA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 70.AUSTRALIA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 71.AUSTRALIA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 72.AUSTRALIA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 74.REST OF ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 75.REST OF ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 76.LAMEA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 77.LAMEA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 78.LAMEA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 79.LAMEA BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 80.BRAZIL BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 81.BRAZIL BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 82.BRAZIL BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 83.SAUDI ARABIA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 84.SAUDI ARABIA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 85.SAUDI ARABIA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 86.SOUTH AFRICA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 87.SOUTH AFRICA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 88.SOUTH AFRICA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 89.REST OF LAMEA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 90.REST OF LAMEA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 91.REST OF LAMEA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 92.KEY ACQUISITION (2017-2021)
TABLE 93.NEW PRODUCT LAUNCHES (2017-2021)
TABLE 94.ASTRAZENECA: COMPANY SNAPSHOT
TABLE 95.ASTRAZENECA: OPERTAING SEGMENTS
TABLE 96.ZYDUS CADILA: PRODUCT PORTFOLIO
TABLE 97.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 98.MERCK & CO.: COMPANY SNAPSHOT
TABLE 99.MERCK & CO.: OPERTAING SEGMENTS
TABLE 100.MERCK & CO.: PRODUCT PORTFOLIO
TABLE 101.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 102.ABBVIE: COMPANY SNAPSHOT
TABLE 103.ABBVIE: PRODUCT PORTFOLIO
TABLE 104.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 105.ABBVIE: KEY DEVELOPMENTAL STRATEGIES
TABLE 106.MYLAN: COMPANY SNAPSHOT
TABLE 107.MYLAN: PRODUCT PORTFOLIO
TABLE 108.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 109.MYLAN: PRODUCT PORTFOLIO
TABLE 110.NOVARTIS: COMPANY SNAPSHOT
TABLE 111.NOVARTIS: OPERATING SEGMENTS
TABLE 112.NOVARTIS: PRODUCT PORTFOLIO
TABLE 113.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 114.PFIZER INC.: COMPANY SNAPSHOT
TABLE 115.PFIZER INC.: OPERATING SEGMENTS
TABLE 116.PFIZER INC.: PRODUCT PORTFOLIO
TABLE 117.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 118.SANOFI: COMPANY SNAPSHOT
TABLE 119.SANOFI: OPERATING SEGMENTS
TABLE 120.SANOFI: PRODUCT PORTFOLIO
TABLE 121.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 122.BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 123.BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 124.TEVA: COMPANY SNAPSHOT
TABLE 125.TEVA: PRODUCT PORTFOLIO
TABLE 126.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 127.ELI LILLY AND COMPANY: COMPANY SNAPSHOT
TABLE 128.ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
TABLE 129.OVERALL FINANCIAL STATUS ($MILLION)
Similar Reports
Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.
Nanomaterials possess nanoscale dimensions ranging from 1 to 100 nanometers. They occur naturally or can be engineered with specific properties such as size, shape, surface, and chemistry. Volcanic ash and forest fibers are some of the examples of natural nano...
- Publish Date: September 10, 2016
- $5820
Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...
- Publish Date: July 4, 2017
- $5370
